BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
This market exercise was for the provision of a solution to advise the detection of IV infiltrations and extravasations early that includes the following:
NHS Supply Chain have a mandate from the Department of Health and Social Care (DHSC) to drive the availability of innovative products to the NHS. NHS Supply Chain believe the product sourced by this contract (which is not covered by any of its current Framework Agreements) falls within this remit as a “disruptive” innovative product and has been identified to provide enhanced patient benefits specifically;
Patient - improving patient safety Prevention of Never Event - which can lead to skin necrosis, Amputation, Nerve Damage for our most vulnerable patients, Neonates, paediatrics, sedated patients, critically ill and patients with cognitive deficits, along with Patients receiving Vesicant medications.
NHS Supply Chain will enter into Framework Agreement (FAG) with an identified supplier of these products/services (alongside the existing framework Infusion Pumps Administration) following the publication of a Transparency notice Published 25 July 2025 [ https://www.find-tender.service.gov.uk/Notice/043122-2025] and no other suppliers were identified. Therefore confirmining 1 available supplier to be awarded using procedure Direct Award as defined in the Procurement Act 2023.
The Term of this Framework Agreement is anticipated to be 12 months, with the option to extend to a maximum term of 48 months. As part of its strategy, NHS Supply Chain anticipates engaging with suppliers of these products/services with a view to ultimately include this solution within the scope of the Framework for Infusion Pumps Administration Sets and Associated products which is due to renewal on 30th September 2026
The Framework Agreement will be between NHS Supply Chain and the Supplier, however 1) NHSSC, 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework.
Electronic ordering will be used, and electronic invoicing will be accepted, and electronic payment will be used.
For the avoidance of doubt and notwithstanding the estimate indicated, NHSSC does not guarantee any level of purchase through the framework and advises applicants that the framework shall be established on a non-exclusive basis.
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| HEALTHCARE 21 (UK) LIMITED | 05020682 | ~£8,000,000 estimated from lot values | 1 lot Lot 1 | - |
Taken from this notice, not from Companies House. Check the original notice — details change and are not updated here.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Awarded To | Status |
|---|---|---|---|
| Lot 1 Sept 2025 – Sept 2026 | £8,000,000 initial term | HEALTHCARE 21 (UK) LIMITED | active |
Government spending data: This supplier has received £4,341,177 in 1,154 payments (over £25k) from NHS Supply Chain (DHSC-funded), Guy's and St Thomas' NHS FT, Manchester University NHS Foundation Trust (2021-11-12 to 2026-02-13). View full payment history →